Real World Health funding news – UK-based Real World Health Secures £1.7Million in Series A Round Funding
Jun 14, 2024 | By Oliver Bennett

Real World Health, a healthcare data analytics company, secures £1.7million in series A round funding. Maven Capital Partners led the round, with Dowgate Capital also participating.
SUMMARY
- Real World Health, a healthcare data analytics company, secures £1.7million in series A round funding.
- RwHealth offers healthcare information and analytics services to businesses in the US, Australia, Scotland, England, and Ireland.
The money will be used by the company to grow both its operations and its clientele. Real World Health is a healthcare and life sciences data solutions business that helps its clients accomplish more with their data. It is led by CEO Scott Fletcher.
Read also - Rendesco funding news – London-based Rendesco Secures £6Million in Funding
With the help of artificial intelligence (AI), Opfeed, an optional theatre optimisation tool, can classify surgeon notes into operations, anticipate how long a surgery would take with machine learning, and plan theatre reservations most efficiently with an algorithm.
RECOMMENDED FOR YOU
Forterro acquisition news – Industrial Software Company Forterro has Acquired Orgadata
Kailee Rainse
Nov 13, 2024
[Funding alert] Austrian Scale-Up, HYDROGRID Secures $8.5 Million in Series-A Round Funding
Oliver Bennett
Dec 21, 2023
Copenhagen-based InsurTech Startup Leaf Secures €1.7 Million Funding
Kailee Rainse
Jun 28, 2025
In addition to physical health, the company works with providers such as Central North West London, South London, and Maudsley to provide mental health data analytics solutions to secondary care providers in the NHS.
About RwHealth
RwHealth offers healthcare information and analytics services to businesses in the US, Australia, Scotland, England, and Ireland. With over a decade of experience, their team of informatics specialists combines cutting-edge technology with industry knowledge to provide the most precise insights and comprehensive analyses. Their solutions, which they customise to meet the exact needs of their clients, are driven by superior information assets that provide actionable insights.
Recommended Stories for You
Valerio Therapeutics acquisition news – Paris-based Valerio Therapeutics Acquired Emglev Therapeutics
Oliver Bennett Sep 30, 2024





